Entering text into the input field will update the search result below

Cellectar Bio plunges 23% after pricing $20M public offering

  • Cellectar Biosciences (NASDAQ:CLRB) has priced its public offering for gross proceeds of $20M.
  • The offering is priced at $1.15/share of common stock and one-half of a Series H Warrant.
  • Each five-year whole Series H Warrant is exercisable to purchase one common share at an exercise price of $1.21/share.
  • Closing date is June 5.
  • Shares are down 23% premarket.

Recommended For You

About CLRB Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CLRB--
Cellectar Biosciences, Inc.